ALUNBRIG 1POINT
Millennium Pharmaceuticals, Inc.
Application Filed: 2017-05-15
Trademark Application Details
PUBLICATION/ISSUE REVIEW COMPLETE
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87449741 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Domestic Representative | Mark I. Peroff |
| Attorney Name | Mark I. Peroff |
| Law Office Assigned | L70 |
| Employee Name | ENGEL, MICHAEL L |
Timeline
| 2017-05-15 | Application Filed |
| 2019-01-07 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-01-07 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
| 2019-02-12 | Published for Opposition |
| 2019-07-30 | Published for Opposition |
Trademark Applicants & Owners
| Owner: |  Millennium Pharmaceuticals, Inc. |
| Address | 40 Landsdowne Street Cambridge DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260131 | Circles |
| 260513 | Triangles, exactly two triangles; Two triangles |
| 260516 | Triangles touching or intersecting |
| 260521 | Triangles that are completely or partially shaded |
| 261701 | Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) |
| 261704 | Bands, vertical; Bars, vertical; Lines, vertical; Vertical line(s), band(s) or bar(s) |
| 261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| PM0001 | ALUNBRIG ONE POINT |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-05-18 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-05-19 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2017-05-20 | 3 MDSM E:E-Mail |
| ASSIGNED TO EXAMINER | 2017-08-09 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-08-17 | 5 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-08-17 | 6 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-08-17 | 7 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-11-14 | 8 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-11-14 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-11-15 | 10 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-11-18 | 11 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-11-18 | 12 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-11-18 | 13 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-05-18 | 14 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-05-18 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-05-19 | 16 TEME I:Incoming Correspondence |
| PRIORITY ACTION WRITTEN | 2018-05-30 | 17 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2018-05-30 | 18 GPRA O:Outgoing Correspondence |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2018-05-30 | 19 GPRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-05-31 | 20 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-05-31 | 21 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-06-01 | 22 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2018-06-20 | 23 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-06-20 | 24 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-06-20 | 25 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2018-06-22 | 26 TCCA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-12-20 | 27 CNSA P: |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2019-01-22 | 28 PBCR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2019-03-05 | 29 ZZZX Z:Deletion |
| NON-FINAL ACTION WRITTEN | 2019-03-05 | 30 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2019-03-05 | 31 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-05 | 32 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-06-07 | 33 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-07 | 34 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-07 | 35 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-10 | 36 CNSA P: |
| ASSIGNED TO LIE | 2019-06-21 | 37 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2019-06-26 | 38 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-07-10 | 39 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-07-30 | 40 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-30 | 41 NPUB E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-08-29 | 42 TCCA I:Incoming Correspondence |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-09-24 | 43 NOAM E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-09-23 | 44 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-09-23 | 45 ARAA I:Incoming Correspondence |
| TEAS EXPRESS ABANDONMENT RECEIVED | 2020-01-06 | 46 EXAR I:Incoming Correspondence |
| ABANDONMENT - AFTER PUBLICATION | 2020-01-07 | 47 ABN5 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | 2020-01-07 | 48 MAB5 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ALUNBRIG 1POINT 87449741 not registered Live/Pending |
Millennium Pharmaceuticals, Inc. 2017-05-15 |
 ALUNBRIG 1POINT 87446257 not registered Live/Pending |
Millennium Pharmaceuticals, Inc. 2017-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 